Pfizer Inc. on Friday said its inhaled insulin drug Exubera has not yet been approved by U.S. regulators and it regrets an incorrect statement it made to business television channel CNBC about the regulatory status of the drug.
The company said it expects that the FDA will issue a decision concerning Exubera shortly.
Not quite yet but hopefully soon!
Whoever wrote this is a clueless idiot. T1 is linked to body weight? Huh?
I can see this being useful for long-term diabetics who have scar tissue built up from decades of shots/pump therapy. Insulin is less effective in those conditions. But I am *seriously* concerned about damage to the lungs from this product.
"It could become another treatment that will cause people to overeat and under-exercise."
And another prejudice idiot spews his tripe without the slightest idea of what the heck he's actually talking about.